{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:53:47Z","timestamp":1754261627496},"reference-count":128,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm. Pat. Analyst"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.4155\/ppa.12.23","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T11:15:19Z","timestamp":1336648519000},"page":"165-175","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological Therapies for Cataract and Refractive Errors: Landscaping Niches of Ocular Drug Patenting"],"prefix":"10.1080","volume":"1","author":[{"given":"Hermann AM","family":"Mucke","sequence":"first","affiliation":[{"name":"H.M. Pharma Consultancy e.U.\rEnenkelstr. 28\/32\rVienna\rA-1160\rAustria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mucke","sequence":"additional","affiliation":[{"name":"H.M. Pharma Consultancy e.U.\rEnenkelstr. 28\/32\rVienna\rA-1160\rAustria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Mucke","sequence":"additional","affiliation":[{"name":"H.M. Pharma Consultancy e.U.\rEnenkelstr. 28\/32\rVienna\rA-1160\rAustria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,5,10]]},"reference":[{"key":"e_1_3_2_3_1_1","unstructured":"Mucke HAM MuckeE MuckePM. The REDWING-D Knowledgebase: Comprehensive Patent Informatics for Ocular Drugs and Diagnostics from 1970 Onward. Poster P-SU-018. Presented at: The World Ophthalmology Congress. Berlin Germany 6 June 2010."},{"key":"e_1_3_2_3_2_1","unstructured":"Mucke HAM MuckeE MuckePM. An analysis of corneal anesthesia data from patents reveals information not represented in the peer review literature. Poster P-SU-010. Presented at: The World Ophthalmology Congress. Berlin Germany 6 June 2010."},{"issue":"1","key":"e_1_3_2_3_3_1","first-page":"30","volume":"13","author":"Mucke HAM","year":"2010","unstructured":"Mucke HAM , MuckePM. Current drug patenting for retinal diseases: beyond VEGF inhibitors. IDrugs13(1) , 30\u201337 (2010).","journal-title":"IDrugs"},{"key":"e_1_3_2_3_4_1","unstructured":"Prevent Blindness America. Vision Problems in the United States: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America (4th Edition). National Eye Institute MD USA (2008)."},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2011.05.021"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2011.08.020"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2009.03.013"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(68)90305-X"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4117.1146"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-010-0778-x"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-010-9177-1"},{"issue":"6","key":"e_1_3_2_3_12_1","first-page":"1473","article-title":"Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.","volume":"41","author":"Saxena P","year":"2000","unstructured":"Saxena P , SaxenaAK, CuiXL et al. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest. Ophthalmol. Vis. Sci. 41(6) , 1473\u20131481 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287394.2011.538835"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/ic102151p"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200506060-00004"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605101103"},{"issue":"6","key":"e_1_3_2_3_17_1","first-page":"449","volume":"14","author":"Tanaka T","year":"1975","unstructured":"Tanaka T , BenedekGB. Observation of protein diffusivity in intact human and bovine lenses with application to cataract. Invest. Ophthalmol.14(6) , 449\u2013456 (1975).","journal-title":"Invest. Ophthalmol."},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014653107"},{"issue":"2","key":"e_1_3_2_3_19_1","first-page":"388","article-title":"Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor beta.","volume":"35","author":"Liu J","year":"1994","unstructured":"Liu J , HalesAM, ChamberlainCG et al. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor beta. Invest. Ophthalmol. Vis. Sci. 35(2) , 388\u2013401 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0820"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0639"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324081"},{"issue":"6","key":"e_1_3_2_3_23_1","first-page":"899","article-title":"Beyond neurological disease: new targets for edaravone.","volume":"28","author":"Kikuchi K","year":"2011","unstructured":"Kikuchi K , UchikadoH, MiyagiN et al. Beyond neurological disease: new targets for edaravone. Int. J. Mol. Med. 28(6) , 899\u2013906 (2011).","journal-title":"Int. J. Mol. Med."},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701921"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e3181ef0da0"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022405"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.185868"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20100303-01"},{"key":"e_1_3_2_4_2_1","unstructured":"Kador PF Wyman M Betts DM: WO2010065024 A1 (2010)."},{"key":"e_1_3_2_4_3_1","unstructured":"Otsuka Pharmaceutical Co. Ltd: WO1998043649 A2 (1998)."},{"key":"e_1_3_2_4_4_1","unstructured":"Chaksu Research Inc.: WO2004058298 A1 (2004)."},{"key":"e_1_3_2_4_5_1","unstructured":"Chaksu Research Inc.: WO2007011843 A2 (2007)."},{"key":"e_1_3_2_4_6_1","unstructured":"Kureha Corp.: WO2005110444 A1 (2005)."},{"key":"e_1_3_2_4_7_1","unstructured":"Santen Pharmaceutical Co. Ltd: WO2006030851 A1 (2006)."},{"key":"e_1_3_2_4_8_1","unstructured":"Senju Pharmaceutical Co. Ltd: WO2009020145 A1 (2009)."},{"key":"e_1_3_2_4_9_1","unstructured":"Burrows Enterprises LLC: WO2009137303 A2 (2009)."},{"key":"e_1_3_2_4_10_1","unstructured":"Korea Institute of Oriental Medicine: WO2011055869 A1 (2011)."},{"key":"e_1_3_2_4_11_1","unstructured":"Delhi Institute of Pharmaceutical Science and Research Promed Exports Private Ltd: WO2009010835 A2 (2009)."},{"key":"e_1_3_2_4_12_1","unstructured":"Massachusetts Institute of Technology: WO1988009660 A2 (1988)."},{"key":"e_1_3_2_4_13_1","unstructured":"Oculon Corp.: WO1993020805 A1 (1993)."},{"key":"e_1_3_2_4_14_1","unstructured":"Oculon Corp.: WO1994026259 A1 (1994)."},{"key":"e_1_3_2_4_15_1","unstructured":"Oculon Corp.: WO1995011884 A1 (1995)."},{"key":"e_1_3_2_4_16_1","unstructured":"CelltrixPharmaceuticals Inc.: WO199401124 A1 (1994)."},{"key":"e_1_3_2_4_17_1","unstructured":"The University of Sydney: WO199513827 A1 (1995)."},{"key":"e_1_3_2_4_18_1","unstructured":"The University of Sydney: WO199826784 A1 (1998)."},{"key":"e_1_3_2_4_19_1","unstructured":"Advanced Medicine Research Institute: WO2004091630 A1 (2004)."},{"key":"e_1_3_2_4_20_1","unstructured":"Advanced Medicine Research Institute: WO2004093882 A1 (2004)."},{"key":"e_1_3_2_4_21_1","unstructured":"Eli Lilly & Co.: WO2002034266 A1 (2002)."},{"key":"e_1_3_2_4_22_1","unstructured":"Newron Pharmaceuticals S.p.A.: WO2004098585 A1 (2004)."},{"key":"e_1_3_2_4_23_1","unstructured":"McMaster University: WO2006113993 A1 (2006)."},{"key":"e_1_3_2_4_24_1","unstructured":"University of East Anglia: WO2011104568 A1 (2011)."},{"key":"e_1_3_2_4_25_1","unstructured":"Oxigene Inc.: WO2011003080 A1 (2011)."},{"key":"e_1_3_2_4_26_1","unstructured":"Pharmacia Groningen BV: WO2004030653 A1 (2004)."},{"key":"e_1_3_2_4_27_1","unstructured":"Pharmacia & Upjohn AB: WO1996034629 A1 (1996)."},{"key":"e_1_3_2_4_28_1","unstructured":"Pharmacia AB: WO1994025020 A1 (1994)."},{"key":"e_1_3_2_4_29_1","unstructured":"Moorsfield Eye Hospital NHS Trust Institute of Ophthalmology University College of London: WO200247728 A2 (2002)."},{"key":"e_1_3_2_4_30_1","unstructured":"American Cyanamid Co.: WO1996012405 A1 (1996)."},{"key":"e_1_3_2_4_31_1","unstructured":"Houston Biotechnology Inc.: WO1995003783 A1 (1995)."},{"key":"e_1_3_2_4_32_1","unstructured":"Houston Biotechnology Inc.: WO1995003828 A1 (1995)."},{"key":"e_1_3_2_4_33_1","unstructured":"Alcon Laboratories Inc.: WO1998024466 A1 (1998)."},{"key":"e_1_3_2_4_34_1","unstructured":"Lankenau Institute for Medical Research: WO2010065920 A1 (2010)."},{"key":"e_1_3_2_4_35_1","unstructured":"Government of the United States of America: WO2004064770 A2 (2004)."},{"key":"e_1_3_2_4_36_1","unstructured":"University of East Anglia: WO2010029350 A1 (2010)."},{"key":"e_1_3_2_4_37_1","unstructured":"University of East Anglia: WO2010029352 A1 (2010)."},{"key":"e_1_3_2_4_38_1","unstructured":"Okada K: WO1999039722 A2 (1999)."},{"key":"e_1_3_2_4_39_1","unstructured":"Okada K: WO200112112 A2 (2011)."},{"key":"e_1_3_2_4_40_1","unstructured":"Biopolymed Inc.: WO2009025527 A2 (2009)."},{"key":"e_1_3_2_4_41_1","unstructured":"The University of Dundee: WO2006021811 A2 (2006)."},{"key":"e_1_3_2_4_42_1","unstructured":"Zhang JJ: WO2006064281 A1 (2006)."},{"key":"e_1_3_2_4_43_1","unstructured":"QLT Phototherapeutics Inc. The University of Dundee: WO1998025610 A1 (1998)."},{"key":"e_1_3_2_4_44_1","unstructured":"Shaw PH Sahli R Sickenberg M et al.: WO1998055641 A2 (1998)."},{"key":"e_1_3_2_4_45_1","unstructured":"Genentech: WO1996013276 (1996)."},{"key":"e_1_3_2_4_46_1","unstructured":"New Vision Co. Ltd: WO1998053806 A1 (1998)."},{"key":"e_1_3_2_4_47_1","unstructured":"Mitsubishi Tanabe Pharma Corp.: WO2007018226 A1 (2007)."},{"key":"e_1_3_2_4_48_1","unstructured":"Alcon Laboratories Inc.: WO2000037072 A1 (2000)."},{"key":"e_1_3_2_4_49_1","unstructured":"Children\u2018s Hospital Medical Center: WO1983003201 A1 (1983)."},{"key":"e_1_3_2_4_50_1","unstructured":"ISTA Pharmaceuticals Inc.: WO2000066139 A2 (2000)."},{"key":"e_1_3_2_4_51_1","unstructured":"The Johns Hopkins University: WO2002030444 A2 (2002)."},{"key":"e_1_3_2_4_52_1","unstructured":"Medigenes Co. Ltd: WO2006096011 A1 (2006)."},{"key":"e_1_3_2_4_53_1","unstructured":"Medigenes Co. Ltd: WO2006091038 A1 (2006)."},{"key":"e_1_3_2_4_54_1","unstructured":"Euclid Systems Corp.: WO2010099102 A1 (2010)."},{"key":"e_1_3_2_4_55_1","unstructured":"Choza Remero AA Choza Remero LE: WO2010011119 A1 (2010)."},{"key":"e_1_3_2_4_56_1","unstructured":"Troisi S Del Prete A Caruso C et al.: WO2011012557 A1 (2011)."},{"key":"e_1_3_2_4_57_1","unstructured":"Seros Medical LLC: WO2011019940 A2 (2011)."},{"key":"e_1_3_2_4_58_1","unstructured":"Euclid Systems Corp.: WO2011031948 A2 (2011)."},{"key":"e_1_3_2_4_59_1","unstructured":"Avedro Inc.: WO2011053768 A2 (2011)."},{"key":"e_1_3_2_4_60_1","unstructured":"Encore Health LLC: WO2010147957 A2 (2010)."},{"key":"e_1_3_2_4_61_1","unstructured":"Encore Health LLC: WO2010147962 A1 (2010)."},{"key":"e_1_3_2_4_62_1","unstructured":"Abbott Medical Optics Inc.: WO2011041437 A1 (2011)."},{"key":"e_1_3_2_4_63_1","unstructured":"Fujisawa Pharmaceutical: WO2000043015 (2000)."},{"key":"e_1_3_2_4_64_1","unstructured":"Senju Pharmaceutical Co. & Green Cross Corp.: WO19950188"},{"key":"e_1_3_2_4_65_1","unstructured":"Green Cross Corp. & Senju Pharmaceutical Co.: WO1994022875 (1994)"},{"key":"e_1_3_2_4_66_1","unstructured":"Senju Pharmaceutical Co. & Green Cross Corp.: WO1994022845 (1994)."},{"key":"e_1_3_2_4_67_1","unstructured":"Green Cross Corp. & Senju Pharmaceutical: WO1994015934 (1994)."},{"key":"e_1_3_2_4_68_1","unstructured":"Yuhan Corp.: WO1994001106 (1994)."},{"key":"e_1_3_2_4_69_1","unstructured":"Senju Pharmaceutical Co.: WO1993023032(1993)."},{"key":"e_1_3_2_4_70_1","unstructured":"Senju Pharmaceutical Co.: WO1992017174 (1992)."},{"key":"e_1_3_2_4_71_1","unstructured":"Pfizer Inc.: WO1992012979 (1992)."},{"key":"e_1_3_2_4_72_1","unstructured":"Pfizer Inc.: WO1991015491 (1991)."},{"key":"e_1_3_2_4_73_1","unstructured":"Alcon Laboratories: WO1983003543 (1983)."},{"key":"e_1_3_2_4_74_1","unstructured":"Alcon Laboratories: WO1983003542 (1983)."},{"key":"e_1_3_2_4_75_1","unstructured":"Seoul National University Industry Foundation: WO2009038288 (2009)."},{"key":"e_1_3_2_4_76_1","unstructured":"Kitasato Institute: WO2008099804 (2008)."},{"key":"e_1_3_2_4_77_1","unstructured":"Mitotechnology LLC: WO2008048134 (2008)."},{"key":"e_1_3_2_4_78_1","unstructured":"Othera Pharmaceuticals Inc.: WO2005055926 (2005)."},{"key":"e_1_3_2_4_79_1","unstructured":"Ader Enterprises Inc.: WO2005041870 (2005)."},{"key":"e_1_3_2_4_80_1","unstructured":"Othera Pharmaceuticals Inc.: WO2003096991 (2003)."},{"key":"e_1_3_2_4_81_1","unstructured":"Santen: WO2001064661 (2001)."},{"key":"e_1_3_2_4_82_1","unstructured":"Johns Hopkins University School of Medicine: WO2000037066 (2000)."},{"key":"e_1_3_2_4_83_1","unstructured":"Senju Pharmaceutical Co.: WO1999055329 (1999)."},{"key":"e_1_3_2_4_84_1","unstructured":"US Dept. of Health and Human Services: WO1997026879 (1997)."},{"key":"e_1_3_2_4_85_1","unstructured":"Alcon Laboratories Inc.: WO1996040107 (1996)."},{"key":"e_1_3_2_4_86_1","unstructured":"Columbia University: WO1995024899 (1995)."},{"key":"e_1_3_2_4_87_1","unstructured":"Arcturus Pharmaceutical Corp.: WO1995017900 (1995)."},{"key":"e_1_3_2_4_88_1","unstructured":"Bruschinetti s.r.l.: WO1995010294 (1995)."},{"key":"e_1_3_2_4_89_1","unstructured":"Santen Pharmaceutical Co. Ltd: WO1994003167 (1994)."},{"key":"e_1_3_2_4_90_1","unstructured":"Individuals: WO1993023028 (1993)."},{"key":"e_1_3_2_4_91_1","unstructured":"Kabushiki Kaisha & Santen Pharmaceutical Co. Ltd: WO1992005789 (1992)."},{"key":"e_1_3_2_4_92_1","unstructured":"Pharmaceutical Santen Co. Ltd: WO1982003393 (1982)."},{"key":"e_1_3_2_4_93_1","unstructured":"Santen Pharmaceutical Co. Ltd: WO1982001000 (1982)."},{"key":"e_1_3_2_4_94_1","unstructured":"University of Munich & Max Planck-Gesellschaft: WO2010089389 (2010)."},{"key":"e_1_3_2_4_95_1","unstructured":"Innovia LLC: WO2007127400 (2007)."},{"key":"e_1_3_2_4_96_1","unstructured":"Bausch & Lomb Inc.: WO2000050101 (2000)."},{"key":"e_1_3_2_4_97_1","unstructured":"Individuals: WO200000106 (2000)."},{"key":"e_1_3_2_4_98_1","unstructured":"IOL Technologie-Production: WO199826652 (1998)."},{"key":"e_1_3_2_4_99_1","unstructured":"Massachusetts Eye & Ear Infirmary: WO199706838 (1997)."},{"key":"e_1_3_2_4_100_1","unstructured":"Houston Biotechnology Inc.: WO199613286 (1996)."},{"key":"e_1_3_2_5_2_1","unstructured":"PatentScope. www.wipo.int\/patentscope"}],"container-title":["Pharmaceutical Patent Analyst"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/ppa.12.23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:40:11Z","timestamp":1715967611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/ppa.12.23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.4155\/ppa.12.23"],"URL":"https:\/\/doi.org\/10.4155\/ppa.12.23","relation":{},"ISSN":["2046-8954","2046-8962"],"issn-type":[{"value":"2046-8954","type":"print"},{"value":"2046-8962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}